The only heart-assist device that allows patients to turn it on and
off is poised for clinical trials. The device is seen as a possible bridge
to heart transplant or as an alternative for nontransplant candidates.
Designed by Adrian Kantrowitz, MD, the Kantrowitz CardioVad System is
ready for the US Food and Drug Administration's (FDA) phase 2 testing protocol.
Kantrowitz performed the first implantation of a partial mechanical heart
intended to remain permanently in a human body in 1966, and he performed the
second human cardiac transplant in the world, the first in the United States,
Mitka M. Midwest Trials of Heart-Assist Device. JAMA. 2001;286(21):2661. doi:10.1001/jama.286.21.2661